We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Emerging Therapeutics in ADH1: Progress in Precision Medicine
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
The Future of ADH1 - Looking at Emergent Treatments
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Therapeutic Options for ADH1 and Hypoparathyroidism
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 2
Malini Gupta, MD, ECNU, FACE
Kaniksha Desai, MD, ECNU, FACE
Rokshana R. Thanadar, MD, FACE, FEAA
Melissa Garduno Young, MD, FACE, FACP, ECNU
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Diagnostic Delay and the Critical Role of Personalized Screening Approaches in Cushing’s Syndrome
Maria Fleseriu, MD, FACE
Martin Reincke, MD
Optimizing Outcomes of Cushing’s Disease Through Strategic Screening, Early Diagnosis, and Timely Treatment
Richard Auchus, MD
Guideline and Evidence-Based Best Practices for Treatment Sequencing
Eliza B. Geer, MD
Susan L Samson, MD, PhD, FRCPC, FACE
Kevin C.J. Yuen, MD
Cushing’s Disease: From Diagnosis to Treatment Selection
When to Screen for Cushing’s Syndrome: Smart & Strategic Screening Approaches
Best Practices for Individualizing Treatment Selection
Recurrence of Cushing’s and the Changing Landscape of Medical Management
How Would You Treat?
Managing TRAEs and Minimizing Hyperglycemia
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education